TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Strata Critical Medical ( (SRTA) ) has issued an announcement.
On December 2, 2025, Strata Critical Medical, Inc. expanded its Board of Directors by appointing William L. Cook, III as a Class I director, effective immediately, with his term expiring at the 2027 annual meeting of stockholders. Mr. Cook, who is deemed independent under Nasdaq rules, will also serve on the Compensation and Nominating and Corporate Governance Committees. His extensive healthcare experience is expected to aid Strata in scaling its organ recovery and logistics platform across the country, enhancing its mission to increase organ availability for transplants and explore broader medical sector services.
The most recent analyst rating on (SRTA) stock is a Buy with a $8.00 price target. To see the full list of analyst forecasts on Strata Critical Medical stock, see the SRTA Stock Forecast page.
Spark’s Take on SRTA Stock
According to Spark, TipRanks’ AI Analyst, SRTA is a Neutral.
Strata Critical Medical’s overall stock score is primarily influenced by its challenging financial performance and bearish technical indicators. Despite positive earnings call guidance and strategic improvements, the negative cash flow and valuation concerns weigh heavily on the score.
To see Spark’s full report on SRTA stock, click here.
More about Strata Critical Medical
Strata Critical Medical, Inc. is a leading provider of logistics and medical services in the organ transplant industry, offering time-critical logistics solutions and specialized medical services to healthcare providers across the United States. The company operates a large air transport and surgical services network for transplant hospitals and organ procurement organizations, providing an integrated solution for donor organ recovery. Strata’s core services include air and ground logistics, surgical organ recovery, organ placement, and perfusion services under the Trinity Medical Solutions and Keystone Perfusion brands.
Average Trading Volume: 898,845
Technical Sentiment Signal: Hold
Current Market Cap: $361M
For a thorough assessment of SRTA stock, go to TipRanks’ Stock Analysis page.